Intracranial extramedullary relapse of acute myeloid leukemia presenting as myeloid sarcoma mimicking meningioma: a case report and literature review - Scorecard - MDSpire
Advertisement
Intracranial extramedullary relapse of acute myeloid leukemia presenting as myeloid sarcoma mimicking meningioma: a case report and literature review
Clinical Scorecard: Isolated Intracranial Myeloid Sarcoma as an Extramedullary Relapse of Acute Myeloid Leukemia: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Myeloid Sarcoma (MS)
Key Mechanisms
Extramedullary tumor of immature myeloid cells, often mimicking meningioma.
Target Population
Patients with a history of acute myeloid leukemia (AML), particularly those in remission.
Care Setting
Oncology and hematology services
Key Highlights
Isolated intracranial MS can occur as an extramedullary relapse in AML patients.
Radiological features may mimic more common neoplasms like meningioma.
Histopathological and immunohistochemical analysis is essential for diagnosis.
Management should follow systemic AML therapy principles.
Guideline-Based Recommendations
Diagnosis
Consider prior history of AML and radiographic features such as restricted diffusion on DWI.
Management
Surgical resection for diagnostic confirmation and therapeutic decompression, followed by systemic chemotherapy.
Monitoring & Follow-up
Regular follow-up for signs of recurrence or new lesions.
Risks
Misdiagnosis due to non-specific clinical and radiological features.
Patient & Prescribing Data
61-year-old female with a history of FLT3-ITD mutated AML.
Post-operative referral for systemic chemotherapy after resection.
Clinical Best Practices
Maintain a high index of suspicion for MS in AML patients presenting with new intracranial masses.
Utilize comprehensive imaging and histopathological evaluation for accurate diagnosis.
